Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125821951 | 12582195 | 1 | I | 20160715 | 20160722 | 20160722 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059149 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160722 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125821951 | 12582195 | 1 | PS | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Unknown | U | 19898 | TABLET | |||||||||
| 125821951 | 12582195 | 2 | C | LYRICA | PREGABALIN | 1 | Unknown | 1 DF, QD | U | 0 | 1 | DF | CAPSULE | QD | |||||
| 125821951 | 12582195 | 3 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | U | 0 | ||||||||||
| 125821951 | 12582195 | 4 | C | PREGABALIN. | PREGABALIN | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | CAPSULE | QD | |||||
| 125821951 | 12582195 | 5 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | CAPSULE | QD | |||||
| 125821951 | 12582195 | 6 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD | |||||
| 125821951 | 12582195 | 7 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Oral | 90 ?G, QID | U | 0 | 90 | UG | QID | ||||||
| 125821951 | 12582195 | 8 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 1 TAB, QD | U | 0 | 1 | DF | TABLET | QD | |||||
| 125821951 | 12582195 | 9 | C | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | Oral | 1 DF, QID | U | 0 | 1 | DF | QID | ||||||
| 125821951 | 12582195 | 10 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Oral | 1 TAB, QD | U | 0 | 1 | DF | QD | ||||||
| 125821951 | 12582195 | 11 | C | DIAZEPAM. | DIAZEPAM | 1 | Oral | 1 DF, BID | U | 0 | 1 | DF | TABLET | BID | |||||
| 125821951 | 12582195 | 12 | C | ACETAMINOPHEN W/HYDROCODONE | ACETAMINOPHENHYDROCODONE | 1 | Oral | 1 TAB, Q8H | U | 0 | 1 | DF | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125821951 | 12582195 | 1 | Product used for unknown indication |
| 125821951 | 12582195 | 2 | Product used for unknown indication |
| 125821951 | 12582195 | 3 | Product used for unknown indication |
| 125821951 | 12582195 | 4 | Product used for unknown indication |
| 125821951 | 12582195 | 5 | Product used for unknown indication |
| 125821951 | 12582195 | 6 | Product used for unknown indication |
| 125821951 | 12582195 | 7 | Product used for unknown indication |
| 125821951 | 12582195 | 8 | Product used for unknown indication |
| 125821951 | 12582195 | 9 | Chronic obstructive pulmonary disease |
| 125821951 | 12582195 | 10 | Product used for unknown indication |
| 125821951 | 12582195 | 11 | Product used for unknown indication |
| 125821951 | 12582195 | 12 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125821951 | 12582195 | Muscle spasms |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125821951 | 12582195 | 4 | 20151229 | 0 | ||
| 125821951 | 12582195 | 5 | 20160426 | 0 | ||
| 125821951 | 12582195 | 7 | 20160201 | 0 | ||
| 125821951 | 12582195 | 8 | 20160125 | 0 | ||
| 125821951 | 12582195 | 11 | 20160210 | 0 | ||
| 125821951 | 12582195 | 12 | 20151218 | 0 |